Skip to main content

Ethambutol-Induced Optic Neuropathy

  • Chapter
  • First Online:
Emergency Neuro-ophthalmology
  • 1068 Accesses

Abstract

A 70-year-old female presented with complaints of gradual blurring OU for 2 months. Her vision dropped from 6/6 to 6/20 in the right eye and from 6/12 to 6/60 in the left within 2 months. According to her family, her medical history included hypertension, cardiac arrhythmia, and controlled hypothyroidism under Eltroxin. She was diagnosed with pulmonary tuberculosis 11 months prior and has since been taking AkuriT-3 (Rifampin 150 mg), isoniazid (75 mg), and ethambutol (275 mg) 4# QD. These medications were discontinued 9 months ago and changed to PZA (500 mg) 3# QD. PZA was used for half a year and was changed to Rifinah (300 mg) 2#QD for 3 weeks and again changed to Levofloxacin (500 mg) 1# QD and Rifampin (150 mg) 4# QD. Her vision notably worsened in the most recent 2 months, despite active revision of antituberculosis medications, so she was referred to our department.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wang MY, Sadun AA. Drug-related mitochondrial optic neuropathies. J Neuroophthalmol. 2013;33(2):172–8.

    Article  CAS  PubMed  Google Scholar 

  2. Kozak SF, Inderlied CB, Hsu HY, Heller KB, Sadun AA. The role of copper on ethambutol’s antimicrobial action and implications for ethambutol-induced optic neuropathy. Diagn Microbiol Infect Dis. 1998;30:83–7.

    Article  CAS  PubMed  Google Scholar 

  3. Santaella RM, Fraunfelder FW. Ocular adverse effects associated with systemic medications: recognition and management. Drugs. 2007;67:75–93.

    Article  PubMed  CAS  Google Scholar 

  4. Lloyd MJ, Fraunfelder FW. Drug-induced optic neuropathies. Drugs Today (Barc). 2007;43:827–36.

    Article  CAS  Google Scholar 

  5. Barron GJ, Tepper L, Iovine G. Ocular toxicity from ethambutol. Am J Ophthalmol. 1974;77:256–60.

    Article  PubMed  CAS  Google Scholar 

  6. Citron KM, Thomas GO. Ocular toxicity from ethambutol. Thorax. 1986;41:737–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Chan RY, Kwok AK. Ocular toxicity of ethambutol. Hong Kong Med J. 2006;12(1):56–60.

    PubMed  CAS  Google Scholar 

  8. Kumar A, Sandramouli S, Verma L, Tewari HK, Khosla PK. Ocular ethambutol toxicity: is it reversible? J Clin Neuroophthalmol. 1993;13:15–7.

    PubMed  CAS  Google Scholar 

  9. Chatterjee VK, Buchanan DR, Friedmann AI, Green M. Ocular toxicity following ethambutol in standard dosage. Br J Dis Chest. 1986;80:288–91.

    Article  PubMed  CAS  Google Scholar 

  10. Schild HS, Fox BC. Rapid-onset reversible ocular toxicity from ethambutol therapy. Am J Med. 1991;90:404–6.

    Article  PubMed  CAS  Google Scholar 

  11. Asayama T. Two cases of bitemporal hemianopsia due to ethambutol. Jpn J Clin Ophthalmol. 1969;23:1209–12.

    Google Scholar 

  12. Kho RC, Al-Obailan M, Arnold AC. Bitemporal visual field defects in ethambutol-induced optic neuropathy. J Neuroophthalmol. 2011;31:121–6.

    Article  PubMed  Google Scholar 

  13. Lee EJ, Kim SJ, Choung HK, Kim JH, Yu YS. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea. J Neuroophthalmol. 2008;28(4):269–77.

    Article  PubMed  Google Scholar 

  14. Sivakumaran P, Harrison AC, Marschner J, Martin P. Ocular toxicity from ethambutol: a review of 4 cases and recommended precautions. N Z Med J. 1998;111:428–30.

    PubMed  CAS  Google Scholar 

  15. Tsai RK, Lee YH. Reversibility of ethambutol optic neuropathy. J Ocul Pharmacol Ther. 1997;13:473–7.

    Article  PubMed  CAS  Google Scholar 

  16. Woung LC, Jou JR, Liaw SL. Visual function in recovered ethambutol optic neuropathy. J Ocul Pharmacol Ther. 1995;11:411–9.

    Article  PubMed  CAS  Google Scholar 

  17. Chen SC, Lin MC, Sheu SJ. Incidence and prognostic factor of ethambutol-related optic neuropathy: 10-year experience in southern Taiwan. Kaohsiung J Med Sci. 2015;31(7):358–62.

    Article  PubMed  CAS  Google Scholar 

  18. Chuenkongkaew W, Samsen P, Thanasombatsakul N. Ethambutol and optic neuropathy. J Med Assoc Thai. 2003;86:622–5.

    PubMed  CAS  Google Scholar 

  19. Sadun AA, Wang MY. Ethambutol optic neuropathy: how we can prevent 100,000 new cases of blindness each year. J Neuroophthalmol. 2008;28:265–8.

    Article  PubMed  Google Scholar 

  20. Chen HY, Lai SW, Muo CH, et al. Ethambutol-induced optic neuropathy: a nationwide population-based study from Taiwan. Br J Ophthalmol. 2012;96:1368–137.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wang, AG. (2018). Ethambutol-Induced Optic Neuropathy. In: Emergency Neuro-ophthalmology . Springer, Singapore. https://doi.org/10.1007/978-981-10-7668-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-7668-8_11

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-7667-1

  • Online ISBN: 978-981-10-7668-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics